GL CHEMTEC Appoints Dr. John Warner as Green Chemistry Innovation Consultant News

[ad_1]

OAKVILLE, Ontario–(BUSINESS WIRE)–Nov. 8, 2022–

GL CHEMTEC (“GLC”), an advanced chemistry R&D and extension services specialist to support active pharmaceutical ingredient (“API”) development and advanced materials development for drug delivery, biomedical materials and other life sciences applications, today is Dr. John Warner has been appointed Green Chemistry Innovation Consultant – Pharma & Biotech. This move reflects GL CHEMTEC’s commitment to the environment and sustainability in R&D and manufacturing.

Dr. John Warner is one of the founders of the field of green chemistry, having written the definitive textbook Green Chemistry: Theory and Practice, which codifies the 12 principles of green chemistry. John holds more than 330 patents and 100 publications in the fields of chemistry and materials science. His inventions have been the basis of companies such as Ambient Photonics, Collaborative Medicinal Development, Collaborative Aggregates and Hairprint. He is co-founder of The Warner Babcock Institute for Green Chemistry and Beyond Benign, a non-profit green chemistry education organization. John continues to work with several companies and organizations and advises on implementing green chemistry principles to facilitate innovation.

Lisa Studnicki Hunt, Ph.D., COO and Founder of GLC said, “John has always been a friend to GLC and has motivated the team to work toward developing more sustainable chemistry on a daily basis. We are delighted that John has decided to join GLC as our Green Chemistry Innovation Consultant to take our pharma and biotech projects to the next level.”

Hamil Alhakimi, Ph.D., MBA, President and Founder of GLC said, “We are thrilled to have John, a world leader in green chemistry, help us focus our services in pharma and biotechnology on sustainable chemical processes. cooperation with our valued customers”.

John Warner, Ph.D., GLC’s Green Chemistry Innovation Advisor, commented, “I look forward to helping GL CHEMTEC increase their influence and impact in the pharmaceutical and biotech industries, creating a sustainable future.”

About GL CHEMTEC:

For nearly 20 years, GL CHEMTEC (“GLC”) has been a leading chemistry-based CRO supporting the pharmaceutical industry and the wider life sciences sector. GLC specializes in advanced multistep organic synthesis, extension services to support R&D and API development, as well as advanced materials for medical devices/biomedical materials, drug delivery and Life Science applications. GLC focuses on the development of new bio-based materials inspired by the 12 principles of Green Chemistry. Operating from two state-of-the-art facilities located in North America, GLC has the experience and capabilities to deliver materials from milligrams to hundreds of kilograms. GLC is a partner of choice from small emerging biotechs to Big Pharma and other Life Science organizations and is known for its speed and client-centric business model. Visit us at www.glchemtec.ca.

See original version on Businesswire.com: https://www.businesswire.com/news/home/20221108006209/en/

CONTACT: GLC:

Lisa Studnicki Hunt

COO

[email protected]

Phone: (416) 803-5358

KEYWORDS: USA NORTH AMERICA CANADA

INDUSTRY KEYWORDS: HEALTHCARE CHEMICALS/PLASTICS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY

SOURCE: GL CHEMTEC

PUB: 08.11.2022 15:33/DISC: 08.11.2022 15:33

http://www.businesswire.com/news/home/20221108006209/kz

[ad_2]

Source link